Department of Gastroenterology and Gastrointestinal Surgery, Hvidovre University Hospital, Hvidovre, Denmark.
United European Gastroenterol J. 2020 Jun;8(5):552-558. doi: 10.1177/2050640620916029. Epub 2020 Apr 23.
Several studies have shown improved short-term outcome with endoscopic transmural drainage and necrosectomy for the treatment of walled-off pancreatic necrosis. However, knowledge on the long-term prognosis after such treatment is limited. The aim of present study was to evaluate long-term outcomes in patients endoscopically treated with transmural drainage and necrosectomy.
We retrospectively follow up 125 patients with walled-off pancreatic necrosis treated with endoscopic transmural drainage and necrosectomy in 2010-2017. All patients received plastic pigtail stents and nasocystic catheter. Additional external drainage was performed in 41 patients. Main outcomes were survival, pancreatic function, development of co-morbidities, ability to work and social status.
During a median follow-up of 4.3 years, nine (7%) patients died. Seven deaths were unrelated to pancreatic disease, and two patients died of pancreatic cancer. Twenty-two (18%) patients developed exocrine pancreatic insufficiency. Thirty-six (32%) previous non-diabetics developed endocrine insufficiency. Endoscopic necrosectomy during admission (odds ratio (OR) = 1.28, 95% confidence interval (CI) 1.05-1.56; = 0.015) and therapy on the main pancreatic duct (OR = 8.08, 95% CI 2.43-26.9; < 0.001) during follow-up predicted development of exocrine insufficiency. Severity on computed tomography predicted endocrine insufficiency (OR = 1.61, 95% CI 1.24-2.09; < 0.001). Most patients regained their working capacity and preserved their marital status.
This study provides robust data on the long-term outcome of patients with walled-off pancreatic necrosis treated with endoscopic transmural drainage and necrosectomy. The favourable outcomes on survival, pancreatic function and social status support current recommendations of endoscopic transmural drainage and necrosectomy being the treatment of choice for walled-off pancreatic necrosis.
多项研究表明,内镜经黏膜下引流和坏死组织清除术治疗胰腺包裹性坏死可改善短期预后。然而,对于此类治疗后的长期预后的相关知识仍很有限。本研究旨在评估内镜经黏膜下引流和坏死组织清除术治疗的患者的长期预后。
我们回顾性随访了 2010 年至 2017 年期间 125 例经内镜经黏膜下引流和坏死组织清除术治疗的胰腺包裹性坏死患者。所有患者均接受了塑料猪尾支架和鼻囊肿引流管。41 例患者还进行了额外的外部引流。主要结局是生存、胰腺功能、合并症的发展、工作能力和社会地位。
在中位随访 4.3 年期间,9 例(7%)患者死亡。7 例死亡与胰腺疾病无关,2 例患者死于胰腺癌。22 例(18%)患者发生外分泌胰腺功能不全。36 例(32%)既往无糖尿病患者发生内分泌功能不全。住院期间行内镜坏死组织清除术(比值比(OR)=1.28,95%置信区间(CI)1.05-1.56;=0.015)和随访期间主胰管治疗(OR=8.08,95%CI 2.43-26.9;<0.001)预测外分泌功能不全的发生。CT 严重程度预测内分泌功能不全(OR=1.61,95%CI 1.24-2.09;<0.001)。大多数患者恢复了工作能力,保持了婚姻状况。
本研究提供了关于经内镜经黏膜下引流和坏死组织清除术治疗胰腺包裹性坏死患者的长期预后的可靠数据。在生存、胰腺功能和社会地位方面的良好结局支持目前的建议,即内镜经黏膜下引流和坏死组织清除术是胰腺包裹性坏死的首选治疗方法。